70860 Federal Register / Vol. 70, No. 225 / Wednesday, November 23, 2005 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Reproductive Health 

in Developing Countries P01 Review. 

Date: December 5, 2005. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Mayflower Hotel, 1127 

Connecticut Avenue, NW., Washington, DC 

20036. 

Contact Person: Carla T. Walls, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, NIH, 6100 

Executive Blvd., Room 5B01, Bethesda, MD 

20892, 301–435–6898, wallsc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: November 8, 2005. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–23201 Filed 11–22–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Eukaryotic 

Pathogens and Vectors. 

Date: November 21, 2005. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: Crystal City Marriott, 1999 Jefferson 

Davis Highway, Arlington, VA 22202. 

Contact Person: Fouad A. El-Zaatari, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

MSC 7808, Bethesda, MD 20814–9692. (301) 

435–1149. elzaataf@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Bioengineering Technology and Surgical 

Sciences. 

Date: November 21, 2005. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Roberto J. Matus, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892. (301) 435–

2204. matusr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Metalloprotein Structure. 

Date: November 21, 2005. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: George W. Chacko, PhD, 

Scientific Review Administrator, Center For 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4186, 

MSC 7849, Bethesda, MD 20892. (301) 435–

1220. chackoge@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 8, 2005. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–23202 Filed 11–22–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Prevention; Notice of Meeting 

Pursuant to Pub. L. 92–463, notice is 

hereby given of the meeting of the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

Drug Testing Advisory Board on 

December 13–14, 2005. 

A portion of the meeting will be open 

and will include a roll call, general 

announcements, a Department of Health 

and Human Services drug testing 

program update, a Department of 

Transportation drug testing program 

update, and a Nuclear Regulatory 

Commission drug testing program 

update. 

Attendance by the public will be 

limited to space available. Public 

comments are welcome. Please 

communicate with the individual listed 

below as contact to make arrangements 

to comment or to request special 

accommodations for persons with 

disabilities. 

The Board will also meet to develop 

the final revisions to the proposed 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs that 

were published in the Federal Register 

on April 13, 2004 (69 FR 19673) and to 

discuss Federal agency specimen 

results, medical review officer 

interpretations, laboratory inspection 

issues, and analytical instrumentation 

issues. This meeting will be conducted 

in closed session since discussing these 

issues in open session will significantly 

frustrate the Department’s ability to 

develop the revisions to the Mandatory 

Guidelines or to disclose information of 

a personal nature where disclosure 

would constitute an unwarranted 

invasion of personal privacy. The HHS 

Office of General Counsel made the 

determination that such matters are 

protected by exemptions (6) and 9(B) of 

section 552b(c) of title 5 U.S.C. and 

therefore may be closed to the public. 

To facilitate entering the building for 

the open session, public attendees are 

Federal Register / Vol. 70, No. 225 / Wednesday, November 23, 2005 / Notices 70861 

required to contact Mrs. Giselle Hersh, 

Division of Workplace Programs, 1 

Choke Cherry Road, Room 2–1042, 

Rockville, MD 20857, 240–276–2605 

(telephone) or by e-mail to 

Giselle.Hersh@samhsa.hhs.gov. 

Substantive program information and 

a roster of Board members may be 

obtained by accessing the SAMHSA 

workplace Web site (http:// 

workplace.samhsa.gov) or 

communicating with the contact whose 

name and telephone number are listed 

below. The transcript for the open 

session will be available on the 

SAMHSA workplace Web site as soon as 

possible after the meeting. 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration Drug Testing Advisory 

Board. 

Meeting Date: December 13–14, 2005. 

Place: SAMHSA Building, Sugarloaf 

Conference Room, 1 Choke Cherry Road, 

Rockville, Maryland 20850. 

Type: Open: December 13, 2005; 8:30 

a.m.–10:30 a.m. 

Closed: December 13, 2005; 10:30 

a.m.–4:30 p.m. 

Closed: December 14, 2005; 8:30 a.m.–

Noon. 

Contact: Donna M. Bush, Ph.D., 

Executive Secretary, 1 Choke Cherry 

Road, Room 2–1033, Rockville, 

Maryland 20857, 240–276–2600 

(telephone) and 240–276–2610 (fax), email: Donna.Bush@samhsa.hhs.gov. 

Dated: November 17, 2005. 

Robert E. Stephenson, 

Acting Committee Management Officer, 

Substance Abuse and Mental Health Services 

Administration. 

[FR Doc. 05–23155 Filed 11–22–05; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[USCG–2005–23024] 

International Code for the Construction 

& Equipment of Ships Carrying 

Dangerous Chemicals in Bulk—

December 2005 Deadline for 

Manufacturers of Affected Products 

AGENCY: Coast Guard, DHS. 

ACTION: Notice. 

SUMMARY: The Coast Guard notifies 

manufacturers that there is a December 

31, 2005 deadline to supply missing 

safety or pollution data for the revised 

International Code for the Construction 

& Equipment of Ships Carrying 

Dangerous Chemicals in Bulk, which 

will affect the bulk shipment of certain 

products on most international voyages. 

DATES: The International Maritime 

Organization should receive missing 

data no later than December 31, 2005. 

ADDRESSES: Missing data can be 

delivered to the following address: 

GESAMP/EHS, International Maritime 

Organization, 4 Albert Embankment, 

London SE1 7SR, United Kingdom. You 

may submit comments identified by 

Coast Guard docket number USCG–

2005–23024 to the Docket Management 

Facility at the U.S. Department of 

Transportation. To avoid duplication, 

please use only one of the following 

methods: 

(1) Web Site: http://dms.dot.gov. 

(2) Mail: Docket Management Facility, 

U.S. Department of Transportation, 400 

Seventh Street, SW., Washington, DC 

20590–0001. 

(3) Fax: 202–493–2251. 

(4) Delivery: Room PL–401 on the 

Plaza level of the Nassif Building, 400 

Seventh Street, SW., Washington, DC, 

between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal holidays. 

The telephone number is 202–366–

9329. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions on this notice, call 

Mr. Tom Felleisen, Hazardous Materials 

Standards Division (G–MSO–3), Coast 

Guard, telephone 202–267–0086. If you 

have questions on viewing or submitting 

material to the docket, call Renee V. 

Wright, Program Manager, Docket 

Operations, telephone 202–493–0402. 

SUPPLEMENTARY INFORMATION: 

Request for Comments 

All comments received will be posted, 

without change, to http://dms.dot.gov 

and will include any personal 

information you have provided. We 

have an agreement with the Department 

of Transportation (DOT) to use the 

Docket Management Facility. Please see 

DOT’s ‘‘Privacy Act’’ paragraph below. 

Submitting comments: If you submit a 

comment, please include your name and 

address, identify the docket number for 

this notice (USCG–2005–23024) and 

give the reason for each comment. You 

may submit your comments by 

electronic means, mail, fax, or delivery 

to the Docket Management Facility at 

the address under ADDRESSES; but 

please submit your comments by only 

one means. If you submit them by mail 

or delivery, submit them in an unbound 

format, no larger than 81⁄2 by 11 inches, 

suitable for copying and electronic 

filing. If you submit them by mail and 

would like to know that they reached 

the Facility, please enclose a stamped, 

self-addressed postcard or envelope. We 

will consider all comments received 

during the comment period. 

Viewing comments and documents: 

To view comments, go to http:// 

dms.dot.gov at any time, click on 

‘‘Simple Search,’’ enter the last five 

digits of the docket number for this 

rulemaking, and click on ‘‘Search.’’ You 

may also visit the Docket Management 

Facility in room PL–401 on the Plaza 

level of the Nassif Building, 400 

Seventh Street, SW., Washington, DC, 

between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal holidays. 

Privacy Act: Anyone can search the 

electronic form of all comments 

received into any of our dockets by the 

name of the individual submitting the 

comment (or signing the comment, if 

submitted on behalf of an association, 

business, labor union, etc.). You may 

review the Department of 

Transportation’s Privacy Act Statement 

in the Federal Register published on 

April 11, 2000 (65 FR 19477), or you 

may visit http://dms.dot.gov. 

Background and Purpose 

The International Maritime 

Organization’s (IMO) Maritime Safety 

Committee adopted the revised 

International Code for the Construction 

& Equipment of Ships Carrying 

Dangerous Chemicals in Bulk (IBC 

Code) last year. Over 120 products were 

omitted from either Chapter 17 or 18 of 

the IBC Code due to missing safety and 

or pollution data. The 41st session of 

the Joint Group of Experts on the 

Scientific Aspects of Marine 

Environmental Protection working 

group on the Evaluation of the Hazards 

of Harmful Substances Carried by Ships 

and the most recent session of the 

working group on the Evaluation of 

Safety and Pollution Hazards updated 

this list. IMO will exclude these 

products from the revised IBC Code 

unless it receives the missing data by 

December 31, 2005. If these products are 

excluded, shippers will be unable to 

carry them in bulk after January 1, 2007 

on most international voyages. 

Therefore, the manufacturers of these 

products should supply the missing 

safety and or pollution data to the IMO 

GESAMP/EHS Secretariat (see 

ADDRESSES) by December 31, 2005. 

This notice of an IMO action does not 

mean that the Coast Guard will 

necessarily be implementing the IMO 

action on all international shipments. 

Implementation of IMO actions would 

be the subject of a future rulemaking 

under a distinct docket. 

The affected products are: 

1. Acetochlor 

2. Alkaryl polyethers (C9–C20) 

3. Alkenyl (C11+) amide